Biotechnology Equipment: Biotech Projects

biotech projects

REUTERS - The Bill & Melinda Gates Foundation said it would invest $52 million in CureVac, a German biotechnology company that develops The foundation will also fund multiple projects developing vaccines for viral, bacterial and parasitic infectious TheStreet Ratings projects a stock's total return potential over a 12-month Celgene (CELG - Get Report) Sub-industry: Biotech Market Cap: $95.7 billion Target Price: $145 Year-to-date return: 6.9% Credit Suisse's Ravi Mehrotra said: Celgene's pipeline Roper established the biotech research institute in March 2013 in a fifth-floor perhaps the SCRA Innovation Center on upper Meeting Street or at the emerging Horizon project near MUSC. As for Mintzer and his staff, the task at hand is to uncover An excellent opportunity has arisen to join a leading biotechnology organisation with a strong global presence on a permanent basis as a Senior Project Coordinator. With an extensive project management skills you will have outstanding attention to detail Curtiss Distinguished Professor in Agriculture and Life Sciences who contributed to the project, said the findings underscore the importance of efforts to educate consumers on the use of biotechnology in the production of healthful food. "This is a What: Shares of Puma Biotechnology (NYSE: PBYI ) , a clinical-stage biopharmaceutical the current standard of care that it was pitted against, leading Wall Street to project peak annual sales of the drug could hit as high as $9 billion, especially .

Signaling a tight market for biotech real estate and the infusion of capital into life sciences companies, developer and landlord HCP Inc. is breaking ground on a massive, high-profile project in South San Francisco. The Irvine-based REIT (NYSE Jonathan Boncek Horizon Project founder CEO Michael Maher says the Horizon district will allow biotech workers and other professionals to mingle and share ideas According to Maher, the Horizon District has the potential to attract a billion dollars worth TORONTO — A Quebec City biotech company has been awarded a contract to make a ZMapp-like product to fight Ebola. The U.S. government's Biomedical Advanced Research and Development Authority issued a contract to make monoclonal Ebola antibodies to Medicago. The project is already a success having allowed the company save best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually .